{"product_id":"memorial-sloan-kettering-cancer-center-hereditary","title":"Memorial Sloan Kettering Cancer Center Hereditary Cancer Genetics Incorporation into Clinical Care 2024","description":"\u003ch3\u003eMemorial Sloan Kettering Cancer Center Hereditary Cancer Genetics Incorporation into Clinical Care 2024\u003c\/h3\u003e\n\u003cstrong\u003eInclude: 34 videos + 28 pdfs, size: 4.78 GB\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003e Target Audience: oncologists, genetic counselors, advanced practice providers\u003c\/strong\u003e\n\u003cbr\u003e\u003cstrong\u003eInformation:\u003c\/strong\u003e\n\u003cbr\u003e\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"form-control-plaintext\"\u003e\n\u003cdiv class=\"form-group\"\u003e\n\u003cdiv class=\"activitysectionbold\"\u003eDate \u0026amp; Location Friday, September 27, 2024, 8:00 AM – Saturday, September 28, 2024, 12:30 PM, Zuckerman Research Center, 417 East 68th Street, New York, NY\u003c\/div\u003e\n\u003cdiv\u003e\n\u003cem\u003eSpecialties\u003c\/em\u003e – Genetics, Oncology and Hematology, Pediatric Oncology, Surgical Oncology\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv\u003eMemorial Sloan Kettering Cancer Center Hereditary Cancer Genetics Incorporation into Clinical Care 2024\u003c\/div\u003e\n\u003cdiv\u003e\u003c\/div\u003e\n\u003cdiv class=\"activitysectionbold\"\u003e\u003cstrong\u003eOverview\u003c\/strong\u003e\u003c\/div\u003e\n\u003cstrong\u003eThis two-day conference provides professional training in clinical cancer genetics, hosted by one of the world’s largest and most renowned cancer genetics centers. \u003c\/strong\u003eThis year’s comprehensive program features presentations and interactive panel discussions led by distinguished experts specializing in disease-specific management. Attendees will have ample opportunities to engage with the faculty during panels and at the networking reception on Friday.\u003cbr\u003e\u003cbr\u003eDesigned to provide a solid foundation in cancer genetics, this conference explores the implications of genetic testing for patient care and showcases the latest advancements in cancer genomics. Highlights of this year’s program include:\u003cbr\u003e\u003cbr\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"activitysectionbold\"\u003e\u003cstrong\u003eObjectives\u003c\/strong\u003e\u003c\/div\u003e\n\u003cdiv\u003eAt the conclusion of this conference, learners will be able to:\u003c\/div\u003e\n\u003col\u003e\n\u003cli\u003eIdentify clinical features of hereditary cancer predisposition syndromes\u003c\/li\u003e\n\u003cli\u003eEvaluate the recommended surveillance and risk reduction interventions for patients with hereditary cancer predisposition syndromes\u003c\/li\u003e\n\u003cli\u003eEnhance awareness of implications of germline genetic testing on therapeutic management of patients with cancer, including oncological and surgical interventions\u003c\/li\u003e\n\u003cli\u003eApply the understanding of tumor profiling results to identify patients at risk for hereditary cancer syndromes\u003c\/li\u003e\n\u003c\/ol\u003e\u003cbr\u003e \u003cbr\u003e\u003cbr\u003e\u003cstrong\u003eTopics:\u003c\/strong\u003e\n\u003cbr\u003e\u003cul\u003e\n\u003cli\u003eArtificial Intelligence in Hereditary Cancer Care.mp4\u003c\/li\u003e\n\u003cli\u003eArtificial Intelligence in Hereditary Cancer Care.pdf\u003c\/li\u003e\n\u003cli\u003eComprehensive Management of Individuals at Risk for Multiple Cancers.mp4\u003c\/li\u003e\n\u003cli\u003eComprehensive Management of Individuals at Risk for Multiple Cancers.pdf\u003c\/li\u003e\n\u003cli\u003eCurrent Topics in Hereditary Gastrointestinal Cancers Q\u0026amp;A.mp4\u003c\/li\u003e\n\u003cli\u003eCurrent Topics in Hereditary Genitourinary Cancers Q\u0026amp;A.mp4\u003c\/li\u003e\n\u003cli\u003eCurrent Topics in Hereditary Gynecologic Cancers Q\u0026amp;A.mp4\u003c\/li\u003e\n\u003cli\u003eDigital Tools to Enhance Access to and Effectiveness of Cancer Genetic Counseling.mp4\u003c\/li\u003e\n\u003cli\u003eDigital Tools to Enhance Access to and Effectiveness of Cancer Genetic Counseling.pdf\u003c\/li\u003e\n\u003cli\u003eEmerging Concepts for the Management of Transgender Individuals at Risk for Hereditary Cancer.mp4\u003c\/li\u003e\n\u003cli\u003eEmerging Concepts for the Management of Transgender Individuals at Risk for Hereditary Cancer.pdf\u003c\/li\u003e\n\u003cli\u003eEmerging Models of Genetic Counseling in Oncology.mp4\u003c\/li\u003e\n\u003cli\u003eEmerging Models of Genetic Counseling in Oncology.pdf\u003c\/li\u003e\n\u003cli\u003eEmerging Opportunities for Targeted Therapies in Rare Cancer Syndromes.pdf\u003c\/li\u003e\n\u003cli\u003eGastrointestinal Cancer Case Studies.mp4\u003c\/li\u003e\n\u003cli\u003eGenetic Testing Models for Peri-Diagnostic Breast Cancer Patients.mp4\u003c\/li\u003e\n\u003cli\u003eGenetic Testing Models for Peri-Diagnostic Breast Cancer Patients.pdf\u003c\/li\u003e\n\u003cli\u003eGenomic Sequencing Q\u0026amp;A.mp4\u003c\/li\u003e\n\u003cli\u003eGermline Implications of Tumor and or Paired Tumor Normal Sequencing.mp4\u003c\/li\u003e\n\u003cli\u003eGermline Implications of Tumor and or Paired Tumor Normal Sequencing.pdf\u003c\/li\u003e\n\u003cli\u003eGuiding Patients through Reproductive and Hormonal Considerations in Hereditary Predisposition Syndromes.mp4\u003c\/li\u003e\n\u003cli\u003eGuiding Patients through Reproductive and Hormonal Considerations in Hereditary Predisposition Syndromes.pdf\u003c\/li\u003e\n\u003cli\u003eHereditary Breast Cancers- Risk Management and Therapeutic Implications.mp4\u003c\/li\u003e\n\u003cli\u003eHereditary Breast Cancers- Risk Management and Therapeutic Implications.pdf\u003c\/li\u003e\n\u003cli\u003eHereditary Gastrointestinal Cancers- Risk Management and Therapeutic Implications.mp4\u003c\/li\u003e\n\u003cli\u003eHereditary Gastrointestinal Cancers- Risk Management and Therapeutic Implications.pdf\u003c\/li\u003e\n\u003cli\u003eHereditary Genitourinary Cancers- Risk Management and Therapeutic Implications.mp4\u003c\/li\u003e\n\u003cli\u003eHereditary Genitourinary Cancers- Risk Management and Therapeutic Implications.pdf\u003c\/li\u003e\n\u003cli\u003eHereditary Gynecologic Cancers- Risk Management and Therapeutic Implications.mp4\u003c\/li\u003e\n\u003cli\u003eHereditary Gynecologic Cancers- Risk Management and Therapeutic Implications.pdf\u003c\/li\u003e\n\u003cli\u003eHereditary Hematologic Cancers.mp4\u003c\/li\u003e\n\u003cli\u003eHereditary Hematologic Cancers.pdf\u003c\/li\u003e\n\u003cli\u003eHereditary Hematologic Malignancies and Rare Cancer Syndromes Q\u0026amp;A.mp4\u003c\/li\u003e\n\u003cli\u003eHereditary Nervous System Tumors- Diagnosis and Risk Management.mp4\u003c\/li\u003e\n\u003cli\u003eHereditary Nervous System Tumors- Diagnosis and Risk Management.pdf\u003c\/li\u003e\n\u003cli\u003eHereditary2024-Brochure.pdf\u003c\/li\u003e\n\u003cli\u003eImpact of Paired Tumor Normal Sequencing on Patient Care.mp4\u003c\/li\u003e\n\u003cli\u003eImpact of Paired Tumor Normal Sequencing on Patient Care.pdf\u003c\/li\u003e\n\u003cli\u003eIntroduction to Cancer Predisposition and Current Topics in Hereditary Breast Cancer Q\u0026amp;A.mp4\u003c\/li\u003e\n\u003cli\u003eIntroduction to Syndromes of Cancer Predisposition.mp4\u003c\/li\u003e\n\u003cli\u003eIntroduction to Syndromes of Cancer Predisposition.pdf\u003c\/li\u003e\n\u003cli\u003eMultidisciplinary Coordination of Care Q\u0026amp;A.mp4\u003c\/li\u003e\n\u003cli\u003ePancreas Cancer Surveillance in High Risk Populations.mp4\u003c\/li\u003e\n\u003cli\u003ePancreas Cancer Surveillance in High Risk Populations.pdf\u003c\/li\u003e\n\u003cli\u003ePediatric Cancer- Genetic Counseling Considerations.mp4\u003c\/li\u003e\n\u003cli\u003ePediatric Cancer- Genetic Counseling Considerations.pdf\u003c\/li\u003e\n\u003cli\u003ePredisposition, Prediction and Prevention- A Window on the Future of Pediatric Cancer.mp4\u003c\/li\u003e\n\u003cli\u003ePredisposition, Prediction and Prevention- A Window on the Future of Pediatric Cancer.pdf\u003c\/li\u003e\n\u003cli\u003ePsychosocial Considerations in the Adoption of Genomic Testing Innovations.mp4\u003c\/li\u003e\n\u003cli\u003ePsychosocial Considerations in the Adoption of Genomic Testing Innovations.pdf\u003c\/li\u003e\n\u003cli\u003eRare Genitourinary Predisposition Syndromes.mp4\u003c\/li\u003e\n\u003cli\u003eRare Genitourinary Predisposition Syndromes.pdf\u003c\/li\u003e\n\u003cli\u003eSurgical Management of Hereditary Colorectal Cancer.mp4\u003c\/li\u003e\n\u003cli\u003eSurgical Management of Hereditary Colorectal Cancer.pdf\u003c\/li\u003e\n\u003cli\u003eSurgical Management of Hereditary Genitourinary Cancers.mp4\u003c\/li\u003e\n\u003cli\u003eSurgical Management of Hereditary Genitourinary Cancers.pdf\u003c\/li\u003e\n\u003cli\u003eSurgical Management of Hereditary Gynecologic Cancer Syndromes.mp4\u003c\/li\u003e\n\u003cli\u003eSurgical Management of Hereditary Gynecologic Cancer Syndromes.pdf\u003c\/li\u003e\n\u003cli\u003eUnderstanding CDKN2A- Managing Melanoma and More.mp4\u003c\/li\u003e\n\u003cli\u003eUnderstanding CDKN2A- Managing Melanoma and More.pdf\u003c\/li\u003e\n\u003cli\u003eUnderstanding the Complexity of Variant Interpretation.mp4\u003c\/li\u003e\n\u003cli\u003eUnderstanding the Complexity of Variant Interpretation.pdf\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003cdiv class=\"visible-md visible-lg\"\u003e\u003c\/div\u003e","brand":"meducours","offers":[{"title":"Default Title","offer_id":42954452205666,"sku":"MED-AMB03870","price":40.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/Memorial-Sloan-Kettering-Cancer-Center-Hereditary-Cancer-Genetics-Incorporation-into-Clinical-Care-2024.jpg?v=1779377157","url":"https:\/\/meducourse.com\/products\/memorial-sloan-kettering-cancer-center-hereditary","provider":"Meducourse","version":"1.0","type":"link"}